GBT

Global Blood Therapeutics, Inc.

Delisted

GBT was delisted on the 4th of October, 2022.

68 hedge funds and large institutions have $470M invested in Global Blood Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$22.6M
2 +$14.7M
3 +$10.2M
4
GGHC
Gilder Gagnon Howe & Co
New York
+$9.6M
5
DM
Deerfield Management
New York
+$8.83M

Top Sellers

1 -$13.4M
2 -$6.81M
3 -$6.15M
4
BG
BlackRock Group
United Kingdom
-$3.7M
5
Millennium Management
Millennium Management
New York
-$3.04M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$148M
2
$38.4M
3
$37.6M
4
$32.3M
5
$22.8M
6
$22.6M
7
$16.3M
8
$14.9M
9
$14.8M
10
$12.9M
11
$10.1M
12
$9.6M
13
$7.07M
14
$6.96M
15
$6.51M
16
$6.45M
17
$6.06M
18
$5.66M
19
$5.53M
20
$5.33M
21
$4.58M
22
$3.56M
23
$2.85M
24
$2.49M
25
$2.46M